Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
2022NSFSC1365
Funder:
Natural Science Foundation of Sichuan Province
Funded outputs count:
14
Funder award ID:
2022NSFSC1365
OpenAlex ID:
G2290282957
Dual-Target Inhibitors Based on COX-2: A Review from Medicinal Chemistry Perspectives
2023
·
Fengmei Zhang
, Guonian Zhu
, et al.
·
Future Medicinal Chemistry
·
8
Correction to “Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies”
2023
·
Tingting Hu
, Jifa Zhang
, et al.
·
Journal of Medicinal Chemistry
·
1
PDF
Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery
2023
·
Wentao Tang
, Congcong Lin
, et al.
·
Journal of Medicinal Chemistry
·
19
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
2023
·
Tingting Hu
, Jifa Zhang
, et al.
·
Journal of Medicinal Chemistry
·
59
Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives
2023
·
Zhendong Niu
, Peng Lei
, et al.
·
European Journal of Medicinal Chemistry
·
44
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site
2023
·
Lun Tan
, Chengyong Wu
, et al.
·
Journal of Medicinal Chemistry
·
41
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects
2023
·
Yijia Chen
, Yuxi Wang
, et al.
·
Journal of Medicinal Chemistry
·
75
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson’s Disease
2023
·
Wen Shuai
, Faqian Bu
, et al.
·
Journal of Medicinal Chemistry
·
28
Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases
2023
·
Xin Xin
, Yue Wang
, et al.
·
European Journal of Medicinal Chemistry
·
38
Targeting ferroptosis: Paving new roads for drug design and discovery
2022
·
Yilin Gu
, Yizhe Li
, et al.
·
European Journal of Medicinal Chemistry
·
89
Targeting FGFRs for Tumor Therapy: Current Status and Novel Strategies
2022
·
Yunzhou Dong
, Changyu Ren
, et al.
·
Future Medicinal Chemistry
·
6
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
2022
·
Kunyu Shi
, Jifa Zhang
, et al.
·
Journal of Medicinal Chemistry
·
50
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
2022
·
Yingxu Fang
, Jiaxing Wang
, et al.
·
Journal of Medicinal Chemistry
·
110
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential
2022
·
Jifa Zhang
, Lele Zhang
, et al.
·
Journal of Medicinal Chemistry
·
102
Show more works
View as search